title: Notes from the field: national shortage of isoniazid 300 mg tablets.
abstract: On November 16, 2012, the Illinois State tuberculosis (TB) program notified CDC's Division of Tuberculosis Elimination of a national shortage of 300 mg tablets of the antituberculosis medication isoniazid (INH). Subsequently, other state TB programs (e.g., California, Indiana, Maryland, New York, Virginia, and Wisconsin) reported difficulty obtaining INH 300 mg tablets. Other programs (e.g., San Diego) have experienced difficulties obtaining at least one of the commercially available anti-TB preparations containing the combination of rifampin and INH (IsonaRif [VersaPharm]).
mesh_terms: D000995:Antitubercular Agents / Q000600:supply & distribution*; D004345:Drug Industry; D006801:Humans; D007538:Isoniazid / Q000600:supply & distribution*; D013607:Tablets; D014376:Tuberculosis / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000995:Antitubercular Agents; D013607:Tablets; D007538:Isoniazid